- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- monomer
- Ligands
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x 6DX: 2-(furan-2-yl)-N~5~-[3-(4-phenylpiperazin-1-yl)propyl][1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.3: 9 residues within 4Å:- Chain A: H.84, G.85, F.88, F.142, M.149
- Ligands: CLR.4, OLA.18, OLA.19, OLB.29
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.88, A:F.88, A:F.142
CLR.4: 9 residues within 4Å:- Chain A: F.71, F.79, A.81, A.82, G.85, F.88, I.89
- Ligands: CLR.3, OLB.28
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:F.71, A:F.79, A:A.81, A:F.88, A:I.89, A:I.89
- Hydrogen bonds: A:A.82
CLR.5: 8 residues within 4Å:- Chain A: L.349, L.352, P.353, F.360, C.367, S.368, L.374
- Ligands: OLA.8
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.349, A:L.352, A:P.353, A:F.360, A:L.374
- Hydrogen bonds: A:S.368
- Water bridges: A:S.368
CLR.6: 8 residues within 4Å:- Chain A: L.196, I.356, C.359, F.360, F.363, C.364
- Ligands: OLA.23, OLB.25
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:L.196, A:I.356, A:F.360, A:F.360, A:F.360, A:F.363
- 17 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
OLA.7: 6 residues within 4Å:- Chain A: T.74, T.77, F.79
- Ligands: OLA.12, OLB.27, OLB.28
Ligand excluded by PLIPOLA.8: 3 residues within 4Å:- Chain A: P.371, L.377
- Ligands: CLR.5
Ligand excluded by PLIPOLA.9: 6 residues within 4Å:- Chain A: F.53, A.106, I.109, D.110, V.125, I.133
Ligand excluded by PLIPOLA.10: 6 residues within 4Å:- Chain A: G.14, S.15, L.372, Y.376, L.377, V.380
Ligand excluded by PLIPOLA.11: 4 residues within 4Å:- Chain A: I.136, I.144
- Ligands: OLA.15, OLB.31
Ligand excluded by PLIPOLA.12: 3 residues within 4Å:- Ligands: OLA.7, OLB.26, OLB.27
Ligand excluded by PLIPOLA.13: 4 residues within 4Å:- Chain A: L.28, L.31, W.38, F.391
Ligand excluded by PLIPOLA.14: 1 residues within 4Å:- Chain A: W.373
Ligand excluded by PLIPOLA.15: 6 residues within 4Å:- Chain A: R.129, G.132, I.133, I.136, V.139
- Ligands: OLA.11
Ligand excluded by PLIPOLA.16: 4 residues within 4Å:- Chain A: V.34, W.38, W.41
- Ligands: OLB.30
Ligand excluded by PLIPOLA.17: 3 residues within 4Å:- Chain A: I.12, S.16
- Ligands: OLB.26
Ligand excluded by PLIPOLA.18: 7 residues within 4Å:- Chain A: I.134, A.135, W.138, F.142
- Ligands: CLR.3, OLA.19, OLB.29
Ligand excluded by PLIPOLA.19: 7 residues within 4Å:- Chain A: H.84, L.146, M.149, L.150
- Ligands: CLR.3, OLA.18, OLB.31
Ligand excluded by PLIPOLA.20: 7 residues within 4Å:- Chain A: I.25, L.28, T.384, V.387, V.388, F.391, Y.395
Ligand excluded by PLIPOLA.21: 1 residues within 4Å:- Chain A: I.392
Ligand excluded by PLIPOLA.22: 1 residues within 4Å:- Chain A: G.345
Ligand excluded by PLIPOLA.23: 10 residues within 4Å:- Chain A: L.196, L.199, L.200, L.203, Y.206, L.207, A.341, A.344, A.348
- Ligands: CLR.6
Ligand excluded by PLIP- 8 x OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)(Non-functional Binders)
OLB.24: 4 residues within 4Å:- Chain A: Y.188, F.192, F.363
- Ligands: OLB.25
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.192, A:F.192
- Hydrogen bonds: A:Y.188
OLB.25: 5 residues within 4Å:- Chain A: F.192, L.196, F.363
- Ligands: CLR.6, OLB.24
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.192, A:L.196, A:F.363, A:F.363
OLB.26: 8 residues within 4Å:- Chain A: P.11, S.15, I.19, L.23, S.76, T.77
- Ligands: OLA.12, OLA.17
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.19, A:L.23, A:T.77
- Hydrogen bonds: A:S.15
OLB.27: 3 residues within 4Å:- Ligands: OLA.7, OLA.12, OLB.28
No protein-ligand interaction detected (PLIP)OLB.28: 11 residues within 4Å:- Chain A: V.66, L.67, P.70, F.71, T.74, F.79, C.80, Q.172
- Ligands: CLR.4, OLA.7, OLB.27
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:L.67, A:P.70, A:F.71, A:T.74, A:F.79
- Hydrogen bonds: A:C.80, A:Q.172, A:Q.172
OLB.29: 13 residues within 4Å:- Chain A: Y.52, V.55, A.59, L.63, L.67, G.127, T.128, A.131, I.134, W.138
- Ligands: CLR.3, OLA.18, OLB.30
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:V.55, A:A.59, A:L.63, A:I.134, A:W.138, A:W.138
OLB.30: 9 residues within 4Å:- Chain A: C.37, W.41, Q.47, Y.52, V.55, A.59, L.63
- Ligands: OLA.16, OLB.29
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:V.55, A:L.63
OLB.31: 9 residues within 4Å:- Chain A: H.84, V.139, A.143, M.149, L.150, G.151, N.153
- Ligands: OLA.11, OLA.19
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:V.139, A:A.143
- Hydrogen bonds: A:M.149, A:N.153
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Segala, E. et al., Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength. J.Med.Chem. (2016)
- Release Date
- 2016-06-29
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- monomer
- Ligands
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x 6DX: 2-(furan-2-yl)-N~5~-[3-(4-phenylpiperazin-1-yl)propyl][1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 17 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
- 8 x OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Segala, E. et al., Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength. J.Med.Chem. (2016)
- Release Date
- 2016-06-29
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.